Xerostomía en pacientes con fibromialgia

Estudio epidemiológico

  • Nicolas Lloves Schenone Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina
  • Felix Romanini Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina
  • Marta Mamani Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina
  • Virginia Durigan Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina
  • Santiago Scarafia Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina
  • Anastasia Secco Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina
Palabras clave: fibromialgia, xerostomía, sialometría, flujo salival, boca seca

Resumen

Introducción: dentro de los fenómenos clínicos estudiados asociados a la Fibromialgia (FM) se ha descrito el Síndrome Sicca, cuyo término engloba xeroftalmia, xerostomía, xerodermia y xerovagina.

Citas

I. Bellato E, Marini E, Castoldi F, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012; 2012:426130.

II. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995 Jan; 38(1):19-28.

III. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb; 33(2):160-72.

IV. Wolfe F. New American College of Rheumatology criteria for fibromyalgia: a twenty-year journey. Arthritis Care and Research. 2010; 62(5):583–584.

V. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research. 2010;62(5):600–610.

VI. Orellana MF, Lagravère MO, Boychuk DG, Major PW, Flores-Mir C. Prevalence of xerostomia in population-based samples: a systematic review. J Public Health Dent. 2006 Spring; 66(2):152-8.

VII. Memtsa PT, Tolia M, Tzitzikas I, Bizakis J, Pistevou-Gombaki K, Charalambidou M, Iliopoulou C, Kyrgias G. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiation therapy. Mol Clin Oncol. 2017 May; 6(5):789-793.

VIII. Guobis Z, Baseviciene N, Paipaliene P, Sabalys G, Kubilius R. Xerostomia: Clinic, etiology, diagnosis and treatment. Medicina (Kaunas) 2006; 42:171–179.

IX. Silvestre-Donat FJ, Miralles-Jordá L, Martinez-Mihi V. Tratamiento de la boca seca: puesta al día. Med Oral 2004; 9:273-9.

X. Morais Everton Freitas de, Macedo Rômulo Augusto de Paiva, Lira Jadson Alexandre da Silva, Lima Kenio Costa de, Borges Boniek Castillo Dutra. Factors related to dry mouth and low salivary flow rates in diabetic elderly: a systematic literature review. Rev. bras. geriatr. gerontol. 2014; 17(2):417-423.

XI. Liquidato BM, Soler Rde C, Bussoloti Filho I. Evaluation of the concordance of sialometry and salivary glands scintigraphy in dry mouth patients. Braz J Otorhinolaryngol. 2006 Jan-Feb; 72(1):116-9.

XII. Agha-Hosseini F, Shirzad N, Moosavi MS. Evaluation of Xerostomia and salivary flow rate in Hashimoto’s Thyroiditis. Med Oral Patol Oral Cir Bucal. 2016 Jan 1; 21(1):e1-5.

XIII. Rad M, Kakoie S, Niliye Brojeni F, Pourdamghan N. Effect of Long-term Smoking on Whole-mouth Salivary Flow Rate and Oral Health. J Dent Res Dent Clin Dent Prospects. 2010; 4(4):110-4.

XIV. Villa A, Abati S. Risk factors and symptoms associated with xerostomia: a cross-sectional study. Aust Dent J. 2011 Sep; 56(3):290-5.

XV. Bonafede RP, Downey DC, Bennett RM. An association of fibromyalgia with primary Sjögren’s syndrome: a prospective study of 72 patients. J Rheumatol. 1995 Jan; 22(1):133-6.

XVI. Choi BY, Oh HJ, Lee YJ, Song YW. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2016 Mar-Apr; 34(2 Suppl 96):S9-13.

XVII. Lee YC, Lu B, Boire G, Haraoui BP, Hitchon CA, Pope JE, Thorne JC, Keystone EC, Solomon DH, Bykerk VP. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort. Ann Rheum Dis. 2013 Jun; 72(6):949-54.

XVIII. Müller W, Schneider EM, Stratz T. The classification of fibromyalgia syndrome. Rheumatol Int. 2007 Sep; 27(11):1005-10.

XIX. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X; International Sjögren’s Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017 Jan; 69(1):35-45.

XX. Franceschini F, Cavazzana I, Andreoli L, Tincani A. (2017). The 2016 classification criteria for primary Sjogren’s syndrome: what’s new? BMC Medicine, 15(1): 69.

Publicado
2018-12-01
Cómo citar
1.
Lloves Schenone N, Romanini F, Mamani M, Durigan V, Scarafia S, Secco A. Xerostomía en pacientes con fibromialgia: Estudio epidemiológico. Rev. Argent. Reumatol. [Internet]. 1 de diciembre de 2018 [citado 31 de enero de 2023];29(4):36 -38. Disponible en: https://ojs.reumatologia.org.ar/index.php/revistaSAR/article/view/499
Sección
Artículo Original